Stem cell therapy uses stem cells or derivatives to stimulate tissue repair in dysfunctional or wounded areas. It is the next stage of organ transplantation, replacing donor organs, which are in short supply. Adult stem cells, such as those produced from adipose tissue, bone marrow, and placental or umbilical stem cells, are found in tiny amounts in most organs. Embryonic stem cells are derived from embryos that are three to five days old. According to emerging evidence, adult stem cells may be capable of producing a variety of cell types.
According to SPER Market Research, ‘Middle East and Africa Stem Cell Therapy Market Size – By Product Type, By Type, By Application, By End User, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ states that the Middle East and Africa Stem Cell Therapy Market is estimated to reach USD 158.57 million by 2033 with a CAGR of 10.53%.
Drivers:
Chronic diseases are becoming more common and widespread.
Chronic diseases are a common health concern around the world. In the Middle East and Africa, one in every three persons has a chronic illness. Chronic diseases have had a negative impact on many persons’ health and quality of life. Chronic diseases, such as cancer, musculoskeletal disorders, neurological disorders, chronic injuries, cardiovascular and gastrointestinal problems, can lead to hospitalisation, long-term disability, a poorer quality of life, and even death.
Mesenchymal stem cells have the ability to penetrate and integrate into a variety of organs, cure cardiovascular, lung, and spinal cord injuries, and improve the status of autoimmune, liver, bone, and cartilage diseases. Stem cells are an effective treatment for conditions marked by inflammation, immune system malfunction, and/or tissue degeneration.
Request for Free Sample Report @ https://www.sperresearch.com/report-store/mea-stem-cell-therapy-market.aspx?sample=1
Restraints:
Research on stem cell-based therapeutics is becoming increasingly expensive.
Stem cell therapy is an advanced and creative treatment option for a variety of disorders. For a variety of conditions, the cost of therapy might be a source of concern. The insurance business and the general public have not embraced stem cell research, which is now highly specialised. Medical insurance does not cover the cost of stem cell research therapies. Patients are compelled to shoulder these costs. It is consequently expected that the current high cost will trend downward.
The COVID-19 epidemic has had a tremendous influence on the healthcare sector, notably the stem cell therapy market in the Middle East and Africa. The pandemic interrupted clinical trials and healthcare systems, but it also highlighted the potential of regenerative medicine in treating COVID-19 long-term effects such as organ damage and immune system dysfunction. The COVID-19 pandemic has fuelled research into stem cell therapy and increased awareness of the need for new therapies for respiratory diseases and other COVID-19-related side effects.
Israel is one of the nations covered by the Middle East and Africa stem cell therapy industry study. Israel is likely to dominate the market as chronic diseases and healthcare costs rise. Major players in the market are U.S. Stem Cell, Inc, STEMPEUTICS RESEARCH PVT LTD, Pluristem Inc, NuVasive, Inc, Mesoblast Limited, Athersys, Inc, and Others.
Middle East and Africa Stem Cell Therapy Market Segmentation:
By Product Type: Based on the Product Type, Middle East and Africa Stem Cell Therapy Market is segmented as; Bone Marrow Derived Mesenchymal Cells, Placental or Umbilical Stem Cell, Adipose Tissue Derived Mesenchymal Stem Cells, and Others.
By Type: Based on the Type, Middle East and Africa Stem Cell Therapy Market is segmented as; Allogenic Stem Cell Therapy and Autologous Stem Cell Therapy.
By Application: Based on the Application, Middle East and Africa Stem Cell Therapy Market is segmented as; Musculoskeletal Disorders, Acute Graft-Versus-Host Disease, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others.
By End User: Based on the End User, Middle East and Africa Stem Cell Therapy Market is segmented as; Hospitals and Surgical Centers, Therapeutic Companies, Services Companies, and Others
By Distribution Channel: Based on the Distribution Channel, Middle East and Africa Stem Cell Therapy Market is segmented as; Direct Tender, Third Party Distributors.
By Region: This research also includes data for South Africa, Egypt, United Arab Emirates, Rest of Middle East and Africa
For More Information, refer to below link: –
Middle East and Africa Stem Cell Therapy Market Forecast
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant – USA
SPER Market Research
+1-347-460-2899
